IQVIA has better operating margins, operational efficiency, strong cash flows, and moderate leverage. See why IQV stock is a ...

An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Cardiff Oncology plans to share additional clinical data from its onvansertib trial in the first half of 2025.

A new clinical study being done at UCSF could change the way doctors treat patients with traumatic brain injuries.

FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...

Kyverna Therapeutics was sued by an investor that lost money from stock that has fallen almost 80% since its February IPO.

This year, we’ve held a series of events to build an open source community and support Llama developers through mentorship, funding and a broad network.

A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...